Gene · 4922
Papers2,041
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,041
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tau-driven degeneration of sleep- and wake-regulating neurons in Alzheimer's disease. | Sleep Med Rev | 2021 | 34500400 | PubTator, text mining | PubMed |
| Advances in Research on Bladder Cancer Targeting Peptides: a Review. | Cell Biochem Biophys | 2021 | 34468956 | PubTator, text mining | PubMed |
| Danger and distress: Parabrachial-extended amygdala circuits. | Neuropharmacology | 2021 | 34461068 | PubTator, text mining | PubMed |
| Potential for Gut Peptide-Based Therapy in Postprandial Hypotension. | Nutrients | 2021 | 34444986 | PubTator, text mining | PubMed |
| Uterine Fibroids and Infertility. | Diagnostics (Basel) | 2021 | 34441389 | PubTator, text mining | PubMed |
Transcriptome Analysis Identifies Doublesex and Mab-3 Related Transcription Factor (DMRT3) in Nasal Polyp Epithelial Cells of Patients Suffering from Non-Steroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease (AERD). | Biomolecules | 2021 | 34439758 | PubTator, text mining | PubMed |
| The Role of Positron Emission Tomography/Computed Tomography (PET/CT) for Staging and Disease Response Assessment in Localized and Locally Advanced Pancreatic Cancer. | Cancers (Basel) | 2021 | 34439307 | PubTator, text mining | PubMed |
| Structural diversity, functional aspects and future therapeutic applications of human gut microbiome. | Arch Microbiol | 2021 | 34405262 | PubTator, text mining | PubMed |
| Repurposing methylene blue in the management of COVID-19: Mechanistic aspects and clinical investigations. | Biomed Pharmacother | 2021 | 34399199 | PubTator, text mining | PubMed |
| Nucleolar release of rDNA repeats for repair involves SUMO-mediated untethering by the Cdc48/p97 segregase. | Nat Commun | 2021 | 34389719 | PubTator, text mining | PubMed |
| Circuit and neuropeptide mechanisms of the paraventricular thalamus across stages of alcohol and drug use. | Neuropharmacology | 2021 | 34389397 | PubTator, text mining | PubMed |
| Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review. | Cancer Drug Resist | 2021 | 34337348 | PubTator, text mining | PubMed |
| Transcription Factor DLX5 Promotes Hair Follicle Stem Cell Differentiation by Regulating the c-MYC/microRNA-29c-3p/NSD1 Axis. | Front Cell Dev Biol | 2021 | 34336814 | PubTator, text mining | PubMed |
| NMU Is a Poor Prognostic Biomarker in Patients with Lung Adenocarcinoma. | Dis Markers | 2021 | 34336003 | PubTator, text mining | PubMed |
| TH1902, a new docetaxel-peptide conjugate for the treatment of sortilin-positive triple-negative breast cancer. | Cancer Sci | 2021 | 34314556 | PubTator, text mining | PubMed |
| Alterations in Gene Expression of Renin-Angiotensin System Components and Related Proteins in Colorectal Cancer. | J Renin Angiotensin Aldosterone Syst | 2021 | 34285715 | PubTator, text mining | PubMed |
| Ionic and signaling mechanisms involved in neurotensin-mediated excitation of central amygdala neurons. | Neuropharmacology | 2021 | 34271017 | PubTator, text mining | PubMed |
| Different roles for the acyl chain and the amine leaving group in the substrate selectivity of N-Acylethanolamine acid amidase. | J Enzyme Inhib Med Chem | 2021 | 34256657 | PubTator, text mining | PubMed |
| Pharmacodynamic and pharmacokinetic profiles of a neurotensin receptor type 2 (NTS2) analgesic macrocyclic analog. | Biomed Pharmacother | 2021 | 34229249 | PubTator, text mining | PubMed |
| Chemoarchitecture of the bed nucleus of the stria terminalis: Neurophenotypic diversity and function. | Handb Clin Neurol | 2021 | 34225977 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4922/papers?page=18